Venous Thromboembolism Prophylaxis in Non-Cardio-Vascular Surgery: A National Survey from the Italian Poly-specialistic Young Surgeons Society (SPIGC)
1.
What your primary surgical specialty?
General Surgery
Neurosurgery
Orthopedic surgery
Oral and maxillofacial surgery
Otorhinolaryngology
Plastic, reconstructive and aesthetic surgery
Thoracic Surgery
Urology
Gynecology and obstetrics
Other, please specify
2.
What is your primary practice setting?
Private practice
Academic Hospital
Non-academic Hospital
Other, specify
3.
How many surgical procedures do your center perform in one year?
Less than 100
101 to 200
201 to 300
301 to 400
401 to 500
More than 500
4.
What kind of surgical procedures do your center perform?
YES
NO
High Complexity Surgery
YES
NO
Intermediate Complexity Surgery
YES
NO
Low Complexity Surgery
YES
NO
5.
Is a predictive risk score for Venous Thromboembolism (VTE) used at your center?
Yes
No
Not sure
6.
Is it mandatory for all surgeons to use this predictive risk score?
Yes
No
Not sure
7.
Do you use to the predictive risk score?
Yes
No
8.
Is a VTE prophylaxis protocol maintained at your center?
Yes
No
Not sure
9.
Is it mandatory for all surgeons to follow this protocol?
Yes
No
Not sure
10.
Do you adhere to the protocol?
Yes
No
11.
In the past 5 years, have you had a patient develop any of the following conditions within 3 months of undergoing a surgery procedure that you performed? (Please include patients only once and select their most severe condition.)
YES
NO
Deep Vein Thrombosis (DVT)
YES
NO
Pulmonary embolism (PE)
YES
NO
Death secondary to VTE
YES
NO
12.
How many patients developed DVT within 3 months of undergoing a procedure that you performed?
13.
How many patients developed PE within 3 months of undergoing a procedure that you performed?
14.
How many patients died within 3 months of undergoing a procedure that you performed?
15.
Do you test for coagulopathies in your patients undergoing surgery?
YES
NO
16.
IF YES, when do you test patients undergoing surgery?
YES
NO
When there is a positive family history bleeding/clotting disorder
YES
NO
When there is a personal history of unexplained DVT or PE
YES
NO
Where there are potential risk factors such as recurrent miscarriage (and/or other possibly c pregnancy complications: intrauterine growth restriction, stillbirth, severe pre-eclampsia and abruptio placentae), obesity, tobacco abuse, history or potus, intravenous drugs abuse.
YES
NO
Other, please specify
17.
IN CASE OF HIGH COMPLEXITY SURGEY
When do you use mechanical prophylaxis and chemoprophylaxis?
YES
NO
Pre-operatively
YES
NO
Intra-operatively
YES
NO
Post-operatively
YES
NO
18.
IN CASE OF HIGH COMPLEXITY SURGEY
Your VTE prophylaxis practice
If any of the following ever affect your decision to use VTE prophylaxis, please mark if you use mechanical prophylaxis (graduated compression stockings, intermittent pneumatic compression devices, intra-operative patient re-positioning) and/or chemoprophylaxis.
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Local Anesthesia
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Sedation
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
General Anesthesia
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 1 hour
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 3 hours
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 6 hours
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Trauma
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Oncological Surgery
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
High-risk of VTE per risk calculator
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of cancer
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of prior DVT and/or PE
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Obese or morbidly obese
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of smoking
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
19.
IN CASE OF HIGH COMPLEXITY SURGEY
Do you routinely prescribe post-operative pharmacological therapy?
YES
NO
20.
IN CASE OF HIGH COMPLEXITY SURGEY
Which preventive pharmacological therapy do you most commonly prescribe?
Aspirin,
Tyclopidin (Tiklid®)
Clopidrogrel (Plavix®),
Heparin
Low-molecular weight heparin (LMWH)
Enoxaparin (Lovenox®)
Vitamin K Inhibitors (coumadin (Wafarin®)
Factor Xa Inhibitors [fondiparinaux (Arixtra®), rivaroxaban (Xarelto®), apixiban (Eliquis®), edoxaban (Savaysa®)]
Thrombin Inhibitors [dabigatran (Pradaxa®), argatroban (Acova®), bivalirudin (Angiomax®), desirudin (Iprivask®), lepirudin (Refludan®)]
Other, please specify
21.
IN CASE OF HIGH COMPLEXITY SURGEY
When you prescribe post-operative drugs, what is the typical duration (in days) that you prescribe? (If you never prescribe anti-coagulants, please enter “0”)
22.
IN CASE OF HIGH COMPLEXITY SURGEY
Which of the following discourages your personal use of pharmacologic VTE prophylaxis on your surgical patients?
YES
NO
Risk of post-operative bleeding or hematoma
YES
NO
Cost
YES
NO
Nuisance to manage
YES
NO
Lack of evidence that prophylaxis in surgery patients is useful after early mobilization
YES
NO
Other, please specify
23.
IN CASE OF HIGH COMPLEXITY SURGEY
Do you give patients post-operative written instructions specific to VTE prevention (i.e. encouraging early ambulation and hydration, seeking medical attention for chest pain, calf pain, shortness of breath, etc.)?
YES
NO
24.
IN CASE OF HIGH COMPLEXITY SURGEY
Do you routinely screen for VTE to discharge?
YES
NO
25.
IN CASE OF HIGH COMPLEXITY SURGEY
If YES, how do you screen for VTE prior to discharge?
Physical exam
D-Dimer
Ultrasound
CT or MR Imaging
Other, please specify
26.
IN CASE OF HIGH COMPLEXITY SURGEY
Do you routinely screen within 30 days of surgery?
YES
NO
27.
IN CASE OF HIGH COMPLEXITY SURGEY
If YES, how do you screen for VTE within 30 days of surgery?
Physical exam
D-Dimer
Ultrasound
CT or MR Imaging
Other, please specify
28.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
When do you use mechanical prophylaxis and chemoprophylaxis?
YES
NO
Pre-operatively
YES
NO
Intra-operatively
YES
NO
Post-operatively
YES
NO
29.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
Your VTE prophylaxis practice
If any of the following ever affect your decision to use VTE prophylaxis, please mark if you use mechanical prophylaxis (graduated compression stockings, intermittent pneumatic compression devices, intra-operative patient re-positioning) and/or chemoprophylaxis.
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Local Anesthesia
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Sedation
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
General Anesthesia
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 1 hour
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 3 hours
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 6 hours
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Trauma
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Oncological Surgery
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
High-risk of VTE per risk calculator
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of cancer
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of prior DVT and/or PE
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Obese or morbidly obese
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of smoking
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
30.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
Do you routinely prescribe post-operative pharmacological therapy?
YES
NO
31.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
Which preventive pharmacological therapy do you most commonly prescribe?
Aspirin,
Tyclopidin (Tiklid®)
Clopidrogrel (Plavix®),
Heparin
Low-molecular weight heparin (LMWH)
Enoxaparin (Lovenox®)
Vitamin K Inhibitors (coumadin (Wafarin®)
Factor Xa Inhibitors [fondiparinaux (Arixtra®), rivaroxaban (Xarelto®), apixiban (Eliquis®), edoxaban (Savaysa®)]
Thrombin Inhibitors [dabigatran (Pradaxa®), argatroban (Acova®), bivalirudin (Angiomax®), desirudin (Iprivask®), lepirudin (Refludan®)]
Other, please specify
32.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
When you prescribe post-operative drugs, what is the typical duration (in days) that you prescribe? (If you never prescribe anti-coagulants, please enter “0”)
33.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
Which of the following discourages your personal use of pharmacologic VTE prophylaxis on your surgical patients?
YES
NO
Risk of post-operative bleeding or hematoma
YES
NO
Cost
YES
NO
Nuisance to manage
YES
NO
Lack of evidence that prophylaxis in surgery patients is useful after early mobilization
YES
NO
Other, please specify
34.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
Do you give patients post-operative written instructions specific to VTE prevention (i.e. encouraging early ambulation and hydration, seeking medical attention for chest pain, calf pain, shortness of breath, etc.)?
YES
NO
35.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
Do you routinely screen for VTE to discharge?
YES
NO
36.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
If YES, how do you screen for VTE prior to discharge?
Physical exam
D-Dimer
Ultrasound
CT or MR Imaging
Other, please specify
37.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
Do you routinely screen within 30 days of surgery?
YES
NO
38.
IN CASE OF INTERMEDIATE COMPLEXITY SURGEY
If YES, how do you screen for VTE within 30 days of surgery?
Physical exam
D-Dimer
Ultrasound
CT or MR Imaging
Other, please specify
39.
IN CASE OF LOW COMPLEXITY SURGEY
When do you use mechanical prophylaxis and chemoprophylaxis?
YES
NO
Pre-operatively
YES
NO
Intra-operatively
YES
NO
Post-operatively
YES
NO
40.
IN CASE OF LOW COMPLEXITY SURGEY
Your VTE prophylaxis practice
If any of the following ever affect your decision to use VTE prophylaxis, please mark if you use mechanical prophylaxis (graduated compression stockings, intermittent pneumatic compression devices, intra-operative patient re-positioning) and/or chemoprophylaxis.
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Local Anesthesia
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Sedation
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
General Anesthesia
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 1 hour
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 3 hours
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Cases lasting greater than 6 hours
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Trauma
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Oncological Surgery
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
High-risk of VTE per risk calculator
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of cancer
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of prior DVT and/or PE
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
Obese or morbidly obese
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
History of smoking
Mechanical Prophylaxis
Chemoprophylaxis
Does not affect my decision
41.
IN CASE OF LOW COMPLEXITY SURGEY
Do you routinely prescribe post-operative pharmacological therapy?
YES
NO
42.
IN CASE OF LOW COMPLEXITY SURGEY
Which preventive pharmacological therapy do you most commonly prescribe?
Aspirin,
Tyclopidin (Tiklid®)
Clopidrogrel (Plavix®),
Heparin
Low-molecular weight heparin (LMWH)
Enoxaparin (Lovenox®)
Vitamin K Inhibitors (coumadin (Wafarin®)
Factor Xa Inhibitors [fondiparinaux (Arixtra®), rivaroxaban (Xarelto®), apixiban (Eliquis®), edoxaban (Savaysa®)]
Thrombin Inhibitors [dabigatran (Pradaxa®), argatroban (Acova®), bivalirudin (Angiomax®), desirudin (Iprivask®), lepirudin (Refludan®)]
Other, please specify
43.
IN CASE OF LOW COMPLEXITY SURGEY
When you prescribe post-operative drugs, what is the typical duration (in days) that you prescribe? (If you never prescribe anti-coagulants, please enter “0”)
44.
IN CASE OF LOW COMPLEXITY SURGEY
Which of the following discourages your personal use of pharmacologic VTE prophylaxis on your surgical patients?
YES
NO
Risk of post-operative bleeding or hematoma
YES
NO
Cost
YES
NO
Nuisance to manage
YES
NO
Lack of evidence that prophylaxis in surgery patients is useful after early mobilization
YES
NO
Other, please specify
45.
IN CASE OF LOW COMPLEXITY SURGEY
Do you give patients post-operative written instructions specific to VTE prevention (i.e. encouraging early ambulation and hydration, seeking medical attention for chest pain, calf pain, shortness of breath, etc.)?
YES
NO
46.
IN CASE OF LOW COMPLEXITY SURGEY
Do you routinely screen for VTE to discharge?
YES
NO
47.
IN CASE OF LOW COMPLEXITY SURGEY
If YES, how do you screen for VTE prior to discharge?
Physical exam
D-Dimer
Ultrasound
CT or MR Imaging
Other, please specify
48.
IN CASE OF LOW COMPLEXITY SURGEY
Do you routinely screen within 30 days of surgery?
YES
NO
49.
IN CASE OF LOW COMPLEXITY SURGEY
If YES, how do you screen for VTE within 30 days of surgery?
Physical exam
D-Dimer
Ultrasound
CT or MR Imaging
Other, please specify
50.
How do you manage asymptomatic DVT?
Observation only
Serial imaging
Pharmacological Therapy
IVC filter placement
Referral primary care physician, vascular surgeon, interventional radiologist, hematologist, other
51.
When do you think the risk is greatest for developing a DVT or PE?
During surgery
Within 7 days of surgery
From 8 to 14 days following surgery
From 15 to 30 days following surgery
From 31 days to 3 months following surgery
52.
When do you think there is no more risk for developing a DVT or PE respect to general population?
After surgery
After hospital discharge
7 days following hospital discharge
15 days following hospital discharge
30 days following hospital discharge
53.
How old are you?
Younger than 25
20-30
30-40
40-50
More than 50
Prefer not to say
54.
What is your gender?
Male
Female
Prefer not to say
55.
How many years have you practiced surgery?
Less than 5 years
5 to 10 years
11 to 20 years
21 to 30 years
More than 30 years
56.
In which Italian region do you practice?
Abruzzo
Basilicata
Calabria
Campania
Emilia-Romagna
Friuli-Venezia Giulia
Lazio
Liguria
Lombardia
Marche
Molise
Piemonte
Puglia
Sardegna
Sicilia
Toscana
Trentino-Alto Adige
Umbria
Val d'Aosta
Veneto
57.
Additional Comments
Avanzamento corrente,
0 di 57 risposte